trastuzumab (Herceptin)
were purchased from Chugai Pharmaceutical (Tokyo, Japan). Nivolumab
(Opdivo) was purchased from Ono Pharmaceutical (Osaka, Japan), and
ramucirumab (Cyramza) was purchased from Eli Lilly Japan (Hyogo, Japan).
Rituximab (Rituxan) was obtained from Zenyaku Kogyo (Tokyo, Japan).
Rapid PNGase F was purchased from New England Biolabs (Tokyo, Japan).
The BlotGlyco kit was from Sumitomo Bakelite Co. Ltd. (Tokyo, Japan),
and PA-glucose oligomer was obtained from TaKaRa (Kyoto, Japan). Sepharose
CL-4B, ribonuclease B (RNase B), bovine fetuin, and LC/MS-grade ammonium
formate were obtained from Sigma-Aldrich (St. Louis, MO). All other
unspecified reagents were products of FUJIFILM Wako Pure Chemical
Corporation (Osaka, Japan).